BioCentury
ARTICLE | Clinical News

Enablex: CTA accepted

May 19, 2008 7:00 AM UTC

In 1H09, BMP Sunstone Corp. (NASDAQ:BJGP, Plymouth Meeting, Pa.) plans to start a Chinese trial of Enablex darifenacin. The company licensed exclusive rights from Novartis to market and distribute En...